Arrowhead Pharma (ARWR) PT Raised to $123 at B.Riley
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $71.86 --0%
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 28
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 28
Join SI Premium – FREE
B.Riley analyst Chad L. Mabry raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $123.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- UBS Upgrades L&T Financial Holdings (LTFH:IN) to Buy
- On Holding AG (ONON) PT Raised to $40 at Needham, 'Bullish Analyst Day Alleviates Growth-Slowdown Fears'
- KB Home (KBH) PT Lowered to $54 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
